Company Filing History:
1 out of 1 
2 out of 832,912 Years Active: 1997-2007
Title: Benedikt Jean: Innovator in Corneal Aberrometry
Introduction
Benedikt Jean is a notable inventor based in Sigmarszell, Germany. He has made significant contributions to the field of ophthalmology, particularly in the area of corneal measurement and surgery. With a total of 3 patents, his work focuses on enhancing the precision of corneal procedures.
Latest Patents
One of his latest patents is titled "Selective Corneal Aberrometry." This invention presents a method and system for measuring and mapping the anterior surface topography of the cornea. It aims to determine corneal aberrations and establish an optimal ablation pattern for refractive and therapeutic surgery. The invention provides real-time visual feedback that accurately portrays the results of topographic surface alterations during an actual ablation procedure. This innovation seeks to achieve minimal corneal aberrations and optimal image quality.
Another significant patent is the "Method and Apparatus for the Simultaneous Determination of Surface Topometry and Biometry of the Eye." This apparatus detects the surface topography of the cornea by projecting a pattern onto its surface and detecting the reflected pattern. It allows for the simultaneous detection of at least one optical property of a layer beneath the cornea, enhancing the understanding of corneal characteristics.
Career Highlights
Benedikt Jean has worked with various companies throughout his career, including Technomed Gesellschaft für Med. und Med. Techn. Systeme mbH. His experience in these organizations has contributed to his expertise in medical technology and innovation.
Collaborations
He has collaborated with notable individuals such as Thomas Bende and Thomas K. Bende, further enriching his professional network and enhancing his contributions to the field.
Conclusion
Benedikt Jean's innovative work in corneal aberrometry and his patents reflect his commitment to advancing ophthalmic technology. His contributions are poised to make a significant impact on the future of refractive and therapeutic eye surgery.